Combined therapy with salmon calcitonin and high doses of active vitamin D3 metabolites in uremic hyperparathyroidism;SKOJARZONE LECZENIE KALCYTONINA I DUZYMI DAWKAMI AKTYWNYCH METABOLITOW WITAMINY D3 WE WTORNEJ DO MOCZNICY NADCZYNNOSCI PRZYTARCZYC

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 1, 1996, Pages 23-31

  Matuszkiewicz Rowińska, Joanna ^a   Niemczyk, Stanisław ^b   Puka, Janusz ^b   Sawicki, Andrzej ^c   Świtalski, Marek ^b   Tałalaj, Marek ^d   Pacocha, Ewa ^a   Marusza, Wojciech ^a   Ostrowski, Kazimierz ^a  

^a Klinika Chorob Wewnetrznych AM W

^b Oddzial Chorob Wewnetrznych/ODSW ^*

^c Ctr Medycznego Szkolenia PWSB

^d Ctr Medycznego Szkolenia PWSC

Author keywords

Active vitamin D3 metabolites; Bone densitometry; Calcitonin; Chronic renal failure; Hemodialysis; Secondary hyperparathyroidism

Indexed keywords

ALFACALCIDOL; ALFAKALCIDOL; CALCITRIOL; SALCATONIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; UREMIA;

EID: 0029801758     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sherrard D. J., Hercz G., Pei Y., Maloney N. A. et al.: The spectrum of bone disease in end-stage renal failure - An evolving disorder. Kidney Int., 1993, 43, 436.
2. Chazan J.A., Libbey N.P., London M.R., Pono L., Abuelo J.G.. The clinical spectrum of renal osteodystropy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Clin. Nephrol., 1991, 35, 78.
3. Malluche H.H., Monier-Faugere M.C.: The changing spectrum of renal bone disease over the last decade. Abstracts of XIIth Int. Congress Nephrol., Jerusalem, 1993, 458.
4. Slatopolsky E., Weerts C., Thielan J., Horst R., Harter H., Martin K.J.: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J. Clin. Invest., 1984, 74, 2136.
5. Malberti F., Surian M., Cosci P.: Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol. Dial. Transplant., 1992, 7, 822.
6. Cannella G., Bonucci E., Rola D. i wsp.: Evidence of healing of secondary hyperparathyroidism in chronically hemodialized uremic patients treated with long-term intravenous calcitriol. Kidney Int., 1994, 46, 1124.
7. Caravaca F., Cubero J.J., Jimenez F. et al.: Effect of mode of calcitriol administration on PTH-ionized calcium relationship in uremic patients with secondary hyperparathyroidism. Nephrol. Dial. Transplant., 1995, 10, 665.
8. 3 pulse therapy. Nephron, 1989, 51, 130.
9. 3 w postaci doustnej - skuteczna metoda hamowania syntezy parathormonu u chorych z zaawansowana̧ nadczynnościa̧ przytarczyc w przebiegu schyłkowej mocznicy. Pol. Arch. Med. Wewn., 1993, 89, 95.
10. Quarles L., Yohay D., Carroll B. i wsp.: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperpathyroidism in ESRD. Kidney Int., 1994, 45, 1710.
11. Stern P.H.: Vitamin D and bone. Kidney Int., 1990, 38, S17.
12. Popovtzer M.M.: The therapeutic roe of 24,25 dihydroxycholecalciferol in dialysis patients with secondary hypaerparathyroidism. Proc. of XIIth Int. Congress of Nephrol. 1991, str. 455.
13. 3. Nephrol. Dial. Transplant., 1995, 10 (S4), 11.
14. Coburn J.W., Slatopolsky E.: Vitamin D, parathyroid hormone, and the renal osteodystrophies. W: Brenner B.M., Rector F.C.: The kidney. Philadelphia, W.B. Sauders Company, 1991.
15. Rodriguez M., Felsenfeld A.J., Torres A., Pederson L., Llach F.: Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat. Kidney Int., 1991, 40, 219.
16. Kokot F.: Metody badań laboratoryjnych stosowanych w klinice. PZWL 1969, 190 i 291.
17. Gruber H.E., Ivey J.L., Baylink D.L., et al: Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism, 1984, 33, 295.
18. Mazzuoli G.F., Passeri M., Gennari C. et al.: Effect of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study, Calcif. Tissue Int., 1986, 38, 3.
19. Cundy T., Kanis J.A., Heynen G., Paton S., Earnshaw M., Woods C.G.: Deterioration of renal bone disease in patients treated with salmon calcitonin. Clin. Endocrinol., 1982, 16, 29.
20. Gennari C., Montagnani M., Nardi P., Zacchei F., Bigazzi S., Cepollaro C.: Long-term effect of cyclic or continuous calcitonin treatment on bone mass in established postmenopausal osteoporosis. W: Christiansen C., Johansen J S., Riis B.J., Osteoporosis 1987 Viborg, Norhaven A/S 1987.
21. Civitelli R., Gonelli S., Zacchei F. et al.: Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. J. Clin. Invest., 1988, 82, 1268.
22. Muff R., Dambacher M.A., Perrenoud A., Simon C., Fischer J.A.: Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. Am. J. Med., 1990, 89, 181.
23. Gennari C.: Zastosowanie kalcytoniny łososia w profilaktyce i leczeniu osteoporozy. Post. Nauk Med., 1990, III, 165.
24. Azria M., Exogenous calcitonin. W: Azria M.: The calcitonins. Karger, Basel, 1989.
25. Reginster J.Y , Denis D., Albert A. et al.: 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. The Lancet, 1987.
26. Francis R.M., Selby P.L., Rodgers A., Davison C.E.: The management of osteoporosis. W: Francis R.M.: Osteoporosis: pathogenesis and management. Kluwer Acad. Publ., London, 1990.
27. Kanis J.A., Aaron J., Thavarajah M. et al.: Osteoporoza: epidemiologia i postȩpowanie terapeutyczne. Post. Nauk Med., 1990, III, 150.
28. Riggs B.L., Theoretical considerations in the treatment of osteoporosis W: Osteoporosis 90, Christiansen C., Overgaard K. Third Int. Symp. On Osteoporosis. Copenhagen 1990, str. 1289.
29. Andress D.L., Norris K.C., Coburn J.W., Slatopolsky E.A., Sherrard D.J.: Intravenous calcttriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N. Engl. J. Med., 1989, 321, 274.
30. Chan T.M., Pun K.K., Cheng I.K.P.: Total and bone densities in dialysis patients. Nephrol. Dial. Transplant., 1992, 7, 835.